(1)
The Dysregulation of Mir-21 and Mir-143 As a Clinical Marker for Cancer Stem Cells in Tissue Samples of Iraqi Male Patients With Gastrointestinal Sarcoma. Journal of Pharmaceutical Negative Results 2022, 13 (3), 20-25. https://doi.org/10.47750/pnr.2022.13.03.004.